AcuraStem Enters into a License Agreement with Takeda to Advance PIKFYVE Therapeutics
/PRNewswire/ -- AcuraStem, a patient-based biotechnology company pioneering how treatments are developed for neurodegenerative diseases, announced today that...
Source: prnewswire.com